Causality assessment methods in drug induced liver injury: Strengths and weaknesses

Journal of Hepatology

Volumn 55, Issue 3, 2011, Pages 683-691

  García Cortés, Miren ^a   Stephens, Camilla ^a   Lucena, M Isabel ^a,b   Fernández Castañer, Alejandra ^a   Andrade, Raúl J ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^b Facultad de Medicina   (Spain)

Author keywords

Causality assessment methods; CIOMS RUCAM scale; Diagnosis; Drug induced liver injury; Hepatotoxicity; Limitations; Risk factors

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BRONCHODILATING AGENT;

ACUTE HEPATITIS; ALGORITHM; AUTHORITY; AUTOIMMUNE DISEASE; CAUSAL ATTRIBUTION; CLINICAL PRACTICE; CLINICAL PROTOCOL; COUNCIL FOR INTERNATIONAL ORGANIZATIONS OF MEDICAL SCIENCES SCALE; DECISION MAKING; DIGESTIVE DISEASE WEEK JAPAN SCALE; DRUG INDUCED DISEASE; EVIDENCE BASED PRACTICE; HEALTH CARE ORGANIZATION; HEPATITIS A; HEPATITIS B; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER INJURY; LIVER TOXICITY; MEDICAL INFORMATION; MEDICAL RESEARCH; MEDICAL SPECIALIST; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RATING SCALE; REVIEW; RISK FACTOR; SCORING SYSTEM;

ALGORITHMS; DRUG-INDUCED LIVER INJURY; HUMANS; LIVER;

EID: 84860389774     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.02.007     Document Type: Review

References (49)

1. Guidance for Industry. Drug-Induced Liver Injury: Premarketing Clinical Evaluation, July 2010. .
2. G. Ostapowicz, R.J. Fontana, Fv. Schiødt, A. Larson, T.J. Davern, and S.H. Han Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States Ann Intern Med 137 2002 947 954 (Pubitemid 35440240)
3. G. Wei, A. Bergquist, U. Broomé, S. Lindgren, S. Wallerstedt, and S. Almer Acute liver failure in Sweden: etiology and outcome J Intern Med 262 2007 393 401 (Pubitemid 47246972)
4. R.J. Andrade, M.I. Lucena, M.C. Fernández, G. Pelaez, K. Pachkoria, and E. García-Ruiz Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period Gastroenterology 129 2005 512 521 (Pubitemid 41096639)
5. R.J. Fontana, P.B. Watkins, H.L. Bonkovsky, N. Chalasani, T. Davern, and J. Serrano Drug-induced liver injury network (DILIN) prospective study rationale, design and conduct Drug Saf 32 2009 55 68
6. A.K. Daly, P.T. Donaldson, P. Bhatnagar, Y. Shen, I. Pe'er, and A. Floratos HLA-B5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin Nat Genet 41 2009 816 819
7. E. Björnsson, and R. Olsson Outcome and prognostic markers in severe drug-induced liver disease Hepatology 42 2005 481 489 (Pubitemid 41061102)
8. M. Molokhia, and P. McKeigue EUDRAGENE: European collaboration to establish a case-control DNA collection for studying the genetic basis of adverse drug reactions Pharmacogenomics 7 2006 633 638
9. R.J. Andrade, M.I. Lucena, N. Kaplowitz, B. García-Munoz, Y. Borraz, and K. Pachkoria Outcome of acute idiosyncratic drug-induced liver injury: long-term follow-up in a hepatotoxicity registry Hepatology 44 2006 1581 1588 (Pubitemid 44953663)
10. R.J. Fontana, L.B. Seeff, R.J. Andrade, E. Björnsson, C.P. Day, and J. Serrano Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop Hepatology 52 2010 730 742
11. G.P. Aithal, P.B. Watkins, R.J. Andrade, D. Larrey, M. Molokhia, and H. Takikawa Case definition and phenotype standardization in drug-induced liver injury Clin Pharmacol Ther 89 2011 806 815
12. M.S. Kramer Assessing causality of adverse drug reactions: global introspection and its limitations Drug Info J 20 1986 433 437 (Pubitemid 17004492)
13. Y. Arimone, B. Bégaud, G. Miremont-Salamé, A. Fourrier-Réglat, N. Moore, and M. Molimard Agreement of expert judgment in causality assessment of adverse drug reactions Eur J Clin Pharmacol 61 2005 169 173 (Pubitemid 40768547)
14. A.F. Macedo, F.B. Marques, and C.F. Ribeiro Can decisional algorithms replace global introspection in the individual causality assessment of spontaneously reported ADRs? Drug Saf 29 2006 697 702 (Pubitemid 44175040)
15. D.C. Rockey, L.B. Seeff, J. Rochon, J. Freston, N. Chalasani, and M. Bonacini Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method Hepatology 51 2010 2117 2126
16. P. Zapater, J. Such, M. Pérez-Mateo, and J.F. Horga A new Poisson and Bayesian-based method to assign risk and causality in patients with suspected hepatic adverse drug reactions: a report of two new cases of ticlopidine-induced hepatotoxicity Drug Saf 25 2002 735 750 (Pubitemid 34983376)
17. F.E. Karch, and L. Lasagna Toward the operational identification of adverse drug reactions Clin Pharmacol Ther 21 1977 247 254 (Pubitemid 8064243)
18. C.A. Naranjo, U. Busto, E.M. Sellers, P. Sandor, I. Ruiz, and E.A. Roberts A method for estimating the probability of adverse drug reactions Clin Pharmacol Ther 30 1981 239 245 (Pubitemid 12149145)
19. M. García-Cortés, M.I. Lucena, K. Pachkoria, Y. Borraz, R. Hidalgo, and R.J. Andrade Evaluation of Naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury Aliment Pharmacol Ther 27 2008 780 789 (Pubitemid 351490076)
20. B.H.C. Stricker Drug-induced hepatic injury 2nd ed. 1992 Amsterdam Elsevier
21. G. Danan, and C. Benichou. Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries J Clin Epidemiol 46 1993 1323 1330 (Pubitemid 23333873)
22. V.A. Maria, and R.M. Victorino Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis Hepatology 26 1997 664 669 (Pubitemid 27392358)
23. H. Takikawa, Y. Takamori, T. Kumagi, M. Onji, M. Watanabe, and A. Shibuya Assessment of 287 Japanese cases of drug induced liver injury by the diagnostic scale of the International Consensus Meeting Hepatol Res 27 2003 192 195 (Pubitemid 37407666)
24. C. Benichou Criteria of drug-induced liver disorders. Report of an international consensus meeting J Hepatol 11 1990 272 276
25. C. Benichou, G. Danan, and A. Flahault Causality assessment of adverse reactions to drugs-II. An original model or validation of drug causality assessment methods: case reports with positive rechallenge J Clin Epidemiol 46 1993 1331 1336 (Pubitemid 23333874)
26. J. Rochon, P. Protiva, L.B. Seeff, R.J. Fontana, S. Liangpunsakul, and P.B. Watkins Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury Hepatology 48 2008 1175 1183
27. M.I. Lucena, R. Camargo, R.J. Andrade, C. Pérez-Sánchez, and F. Sánchez De La Cuesta Comparison of two clinical scales for causality assessment in hepatotoxicity Hepatology 33 2001 123 130 (Pubitemid 32016894)
28. M. Watanabe, and A. Shibuya Validity study of a new diagnostic scale for drug-induced liver injury in Japan-comparison with two previous scales Hepatol Res 30 2004 148 154 (Pubitemid 39654745)
29. C. Stephens, M.I. Lopez-Nevot, M.I. Lucena, F. Ruiz-Cabello, E. Ulzurrun, and M.C. Cabello The HLA class I B1801 allele influences hepatocellular expression of amoxicillin-clavulanate liver damage and outcome in Spanish patients J Hepatol 52 2010 S439
30. P.B. Watkins Biomarkers for the diagnosis and management of drug-induced liver injury Semin Liver Dis 29 2009 393 399
31. G.P. Aithal, M.D. Rawlins, and C.P. Day Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions J Hepatol 33 2000 949 952
32. K. Tajiri, and Y. Shimizu Practical guidelines for diagnosis and early management of drug-induced liver injury World J Gastroenterol 14 2008 6774 6785
33. P.H. Hayashi Causality assessment in drug-induced liver injury Sem Liv Dis 29 2009 348 356
34. M.A. Shapiro, and J.H. Lewis Causality assessment of drug-induced hepatotoxicity: promises and pitfalls Clin Liver Dis 2007 477 505 (Pubitemid 47302343)
35. M.I. Lucena, R.J. Andrade, M.C. Fernándes, K. Pachkoria, G. Pelaez, and J.A. Durán Determinants of the clinical expression of amoxicillin-clavulanate hepatotoxicity: a prospective series from Spain Hepatology 44 2006 850 856 (Pubitemid 46489548)
36. M.I. Lucena, R.J. Andrade, N. Kaplowitz, M. García-Cortes, M.C. Fernández, and M. Romero-Gomez Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex Hepatology 49 2009 2001 2009
37. C.K. Fairley, J.J. McNeil, P. Desmond, R. Smallwood, H. Young, and A. Forbes Risk factors for development of flucloxacillin associated jaundice BMJ 306 1993 233 235 (Pubitemid 23027961)
38. C.M. Nolan, S.V. Goldberg, and S.E. Buskin Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic JAMA 281 1999 1014 1018 (Pubitemid 29143893)
39. N. Chalasani, and E. Björnsson Risk factors for idiosyncratic drug-induced liver injury Gastroenterology 138 2010 2246 2259
40. R.J. Andrade, M. Robles, E. Ulzurrun, and M.I. Lucena Drug-induced liver injury: insights from genetic studies Pharmacogenomics 10 2009 1467 1487
41. M.I. Lucena, R.J. Andrade, L. Vicioso, F.J. González, K. Pachkoria, and B. García-Muñoz Prolonged cholestasis after raloxifene ad fenofibrate interaction: a case report World J Gastroenterol 12 2006 5244 5246 (Pubitemid 44355928)
42. S. Verma, and N. Kaplowitz Diagnosis, management and prevention of drug-induced liver injury Gut 58 2009 1555 1564
43. H.R. Dalton, H.J. Fellows, W. Stableforth, M. Joseh, P.H. Thurairajah, and U. Warshow The role of hepatitis E virus testing in drug-induced liver injury Aliment Pharmacol Ther 26 2007 1429 1435 (Pubitemid 350045603)
44. A. Suzuki, R.J. Andrade, E. Björnsson, M.I. Lucena, W.M. Lee, and N.A. Yuen Drugs associated with hepatotoxicity and their reporting frequency of liver adverse events in VigiBase™: unified list based on international collaborative work Drug Saf 33 2010 503 522
45. R.J. Andrade, M. Robles, and M.I. Lucena Rechallenge in drug-induced liver injury: the attractive hazard Expert Opin Drug Saf 8 2009 709 714
46. R.J. Andrade, M. Robles, A. Fernández-Castañer, S. López-Ortega, M.C. López-Vega, and M.I. Lucena Assessment of drug-induced hepatotoxicity in clinical practice. a challenge for gastroenterologists World J Gastroenterol 13 2007 329 340 (Pubitemid 46178965)
47. D.E. Kleiner The pathology of drug-induced liver injury Semin Liver Dis 29 2009 364 372
48. D. Larrey Epidemiology and individual susceptibility to adverse drug reactions affecting the liver Semin Liver Dis 22 2002 145 155 (Pubitemid 34496468)
49. N. Kaplowitz Causality assessment versus guilt-by-association in drug hepatotoxicity Hepatology 33 2001 308 310 (Pubitemid 32016915)